Neuren Pharmaceuticals Limited is a biopharmaceutical company developing drugs for brain injury and neurodegeneration. The drugs target acute indications of brain injury such as traumatic brain injury, as well as chronic conditions such as Parkinson’s and Alzheimer’s diseases.
View Top Employees from Neuren Pharmaceuticals| Website | https://www.neurenpharma.com |
| Ticker | NEU |
| Revenue | $10 million |
| Employees | 18 (18 on RocketReach) |
| Founded | 2004 |
| Phone | +61 3 9092 0480 |
| Fax | (649) 361-7981 |
| Technologies |
JavaScript,
HTML,
Twitter
+10 more
(view full list)
|
| Industry | Pharmaceuticals, Biotechnology, Business Services General, Biopharma, Business Services, Health Care, Science and Engineering, Therapeutics |
| Web Rank | 8 Million |
| Keywords | Neuren Pharmaceuticals, Neuren Stock, Nnz-2566, Neuren, Neuren Pharmaceuticals Shares |
| Competitors | Biokine Therapeutics Ltd., Leap Therapeutics, Neuraltus Pharmaceuticals, OYAGEN INC., Step Pharma |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Neuren Pharmaceuticals employee's phone or email?
Neuren Pharmaceuticals Questions
The Neuren Pharmaceuticals annual revenue was $10 million in 2024.
Lauren Frazer is the CFO of Neuren Pharmaceuticals.
18 people are employed at Neuren Pharmaceuticals.
Neuren Pharmaceuticals is based in Auckland, Auckland.
The NAICS codes for Neuren Pharmaceuticals are [325, 32541, 3254, 32].
The SIC codes for Neuren Pharmaceuticals are [28, 283].
Top Neuren Pharmaceuticals Employees
-
14
-
22
-
1
-
5+
-
2
-
View
Nancy Jones
Vice President, Clinical Development at Neuren Pharmaceuticals
Birmingham, England, United Kingdom2 -
45+
-
23
Related Companies
